Feature Channels: Vaccines

Filters close
Released: 12-Sep-2023 1:45 PM EDT
Mount Sinai Receives NIH Grant to Develop Vaccines That Can Protect Against Many Different Types of Coronaviruses
Mount Sinai Health System

$13 million will fund a multidisciplinary, multi-institution team effort to develop stronger and more versatile vaccines

Not for public release

This news release is embargoed until 11-Sep-2023 5:00 PM EDT Released to reporters: 5-Sep-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 6-Sep-2023 10:25 AM EDT
Third NIH Grant Moves Novel Anti-Diarrheal Vaccine Forward
College of Veterinary Medicine, University of Illinois Urbana-Champaign

Dr. Weiping Zhang, professor in the Department of Pathobiology, was recently awarded a five-year, $5.6 million R01 grant from the National Institutes of Health (NIH) to optimize a promising vaccine against enterotoxigenic Escherichia coli (ETEC).

Released: 5-Sep-2023 2:05 PM EDT
New study shows effectiveness of mpox vaccine
Queen Mary University of London

A new international study led by Queen Mary University of London has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination.

Released: 5-Sep-2023 10:30 AM EDT
وجد باحثو مايو كلينك أن اللقاح قد يُقلِّل من شدة أعراض كوفيد طويلة الأمد
Mayo Clinic

إن تلقي لقاح كوفيد-19 قد لا يُقلِّل فقط من خطر إصابة الشخص بكوفيد طويل الأمد، ولكنه قد يعني أيضًا أعراضًا أقل للأشخاص الذين يُصابون بهذه الحالة.

Released: 5-Sep-2023 10:20 AM EDT
Pesquisadores da Mayo descobrem que vacina pode reduzir a gravidade dos sintomas da COVID de longa duração
Mayo Clinic

Tomar a vacina contra COVID-19 pode não só reduzir os riscos de uma pessoa contrair COVID de longa duração, mas também pode significar a redução dos sintomas para a pessoa que desenvolver a doença.

Released: 5-Sep-2023 9:05 AM EDT
Investigadores de Mayo descubren que la vacuna puede reducir la gravedad de los síntomas del síndrome crónico de COVID
Mayo Clinic

Recibir la vacuna contra la COVID-19 podría significar no solo un menor riesgo de tener síndrome crónico de COVID, sino también la presencia de menos síntomas para quienes contraigan la afección.

Newswise: Mapping the coronavirus spike protein could provide insight into vaccine development
Released: 1-Sep-2023 2:55 PM EDT
Mapping the coronavirus spike protein could provide insight into vaccine development
University of Missouri, Columbia

Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.

Newswise: LJI scientists harness 'helper' T cells to treat tumors
31-Aug-2023 1:05 PM EDT
LJI scientists harness 'helper' T cells to treat tumors
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) scientists have published a pair of studies that show how we might harness CD4+ T cells while boosting the cancer-fighting power of CD8+ "killer" T cells.

Released: 31-Aug-2023 4:40 PM EDT
Digging deeper into how vaccines work against parasitic disease
Ohio State University

Researchers have determined how Leishmaniasis vaccine candidates, created using mutated disease-causing parasites, prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.

29-Aug-2023 8:00 AM EDT
Scancell's DNA-based vaccine shown to be effective at protecting against COVID-19
Texas Biomedical Research Institute

A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine.

Newswise: Research shaped career of O’Donnell School of Public Health leader
Released: 28-Aug-2023 10:05 AM EDT
Research shaped career of O’Donnell School of Public Health leader
UT Southwestern Medical Center

Saad B. Omer, M.B.B.S., M.P.H., Ph.D., Founding Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center, discovered a passion for public health while he was a medical student in Pakistan.

Newswise: Study Shows Technology Boosts Public Health Programs
Released: 24-Aug-2023 5:05 PM EDT
Study Shows Technology Boosts Public Health Programs
University of Utah Health

SCALE-UP Counts was designed to promote COVID-19 testing in local schools. Huntsman Cancer Insitute’s Yelena Wu, PhD, hopes the insight gained from the program improves cancer screening and education initiatives.

Newswise: COVID-19, Flu and RSV vaccines — what you need to know
Released: 24-Aug-2023 12:00 PM EDT
COVID-19, Flu and RSV vaccines — what you need to know
Keck Medicine of USC

Keck Medicine of USC experts discuss new recommendations for staying healthy and safe during the respiratory virus season

Released: 23-Aug-2023 2:15 PM EDT
Study finds high levels of exposure to the COVID-19 virus may reduce protection provided by vaccination and prior infection
Yale University

High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study.

Newswise:Video Embedded mayo-researchers-find-vaccine-may-reduce-severity-of-long-haul-covid-symptoms
VIDEO
Released: 23-Aug-2023 12:50 PM EDT
Mayo researchers find vaccine may reduce severity of long-haul COVID symptoms
Mayo Clinic

Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.

Released: 23-Aug-2023 12:45 PM EDT
Research identifies immunosuppressed people are least likely to have COVID-19 antibodies
University of Nottingham

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

Newswise: Many older adults want RSV vaccine, poll shows
Released: 22-Aug-2023 10:15 AM EDT
Many older adults want RSV vaccine, poll shows
Michigan Medicine - University of Michigan

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

Released: 21-Aug-2023 3:05 PM EDT
COVID-19 vaccines are effective against severe cases in children
Murdoch Childrens Research Institute

A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.

Newswise: Back-to-School: Preparing Children for a Healthy, Happy Year
Released: 21-Aug-2023 12:25 PM EDT
Back-to-School: Preparing Children for a Healthy, Happy Year
Cedars-Sinai

The temperature feels like summer is still in full swing, yet this week, thousands of Los Angeles schoolchildren headed back to the classroom.

Newswise: Scientists Develop Efficient Spray Technique for Bioactive Materials
Released: 18-Aug-2023 1:05 PM EDT
Scientists Develop Efficient Spray Technique for Bioactive Materials
Rutgers University-New Brunswick

Rutgers scientists have devised a highly accurate method for creating coatings of biologically active materials for a variety of medical products. Such a technique could pave the way for a new era of transdermal medication, including shot-free vaccinations, the researchers said.

   
Newswise: Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Released: 18-Aug-2023 12:05 PM EDT
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Johns Hopkins Medicine

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.

Newswise: Rutgers Scientist’s Research Provides Insight Into COVID-19 Immunity
Released: 17-Aug-2023 1:50 PM EDT
Rutgers Scientist’s Research Provides Insight Into COVID-19 Immunity
Rutgers University-New Brunswick

Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.

Newswise: Assessment of immunological reaction to mRNA SARS CoV-2 vaccine after administration of Tixagevimab/Cilgavimab, using B cell receptor repertoire analysis
Released: 17-Aug-2023 1:10 PM EDT
Assessment of immunological reaction to mRNA SARS CoV-2 vaccine after administration of Tixagevimab/Cilgavimab, using B cell receptor repertoire analysis
Kobe University

A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire(*1) has been developed by a research group.

Newswise: Back-to-School: How to Help Young Children Return to the Classroom
Released: 17-Aug-2023 11:55 AM EDT
Back-to-School: How to Help Young Children Return to the Classroom
Cedars-Sinai

The start of the school year can be tough for many children. For some, the struggle might last just a few days. For others, however, a difficult transition back to school might be a sign of an undetected behavioral or developmental condition that requires medical attention.

Newswise:Video Embedded gender-based-research-project-provides-african-women-farmers-with-access-to-livestock-vaccines
VIDEO
Released: 17-Aug-2023 10:05 AM EDT
Gender-Based Research Project Provides African Women Farmers with Access to Livestock Vaccines
Tufts University

Before they had access to livestock vaccines, many women in rural parts of Africa who manage livestock had to resort to traditional medicines when their animals got sick, or suffer loss of their animals.

Newswise: Several vaccines associated with reduced risk of Alzheimer’s disease in adults 65 and older
Released: 16-Aug-2023 3:50 PM EDT
Several vaccines associated with reduced risk of Alzheimer’s disease in adults 65 and older
University of Texas Health Science Center at Houston

Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.

Released: 16-Aug-2023 1:30 PM EDT
As Kids Go Back To School, Parents Prepare For A Healthy School Year
Hackensack Meridian Health

Variety of health back to school pitches from the experts at Hackensack Meridian Children's Health

Newswise: A ‘FAAIRI’s touch to ease children’s fear of needles
Released: 14-Aug-2023 8:40 PM EDT
A ‘FAAIRI’s touch to ease children’s fear of needles
University of South Australia

Vaccinations, blood tests, or IVs – it’s fair to say that no child likes a needle. So, when it comes to the jab, a light touch and a caring approach is incredibly welcomed – both by the child and the parent. Now, world-first research from the University of South Australia shows that while many children suffer distress, new ultrasound-guided techniques could provide much-needed reprieve.

Released: 14-Aug-2023 1:45 PM EDT
Surprise COVID discovery helps explain how coronaviruses jump species
University of Virginia Health System

Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species to species and will help scientists better predict how COVID-19 will evolve.

Released: 10-Aug-2023 4:05 PM EDT
Back to school: MSU experts on health and safety issues for students
Michigan State University

Over 50 million K-12 students across the United States will return to classrooms this month, according to the National Center for Education Statistics. Michigan State University experts provide guidance on how to ensure students are physically and mentally prepared for the new school year.

   
Newswise: Community health program boosts child vaccinations in remote areas of Madagascar
Released: 10-Aug-2023 3:45 PM EDT
Community health program boosts child vaccinations in remote areas of Madagascar
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Madagascar is one of the poorest countries in the world and access to health care is limited for many people. A new study from the University of Illinois Urbana-Champaign examines the effectiveness of a health intervention program that enlists community-based health workers to promote child vaccination uptake.

Released: 10-Aug-2023 2:45 PM EDT
As Kids Go Back To School, Parents Prepare For A Healthy School Year
Hackensack Meridian Health

Medical experts offer tips on various back to school health concerns to prepare for a healthy successful school year.

Newswise: Guiding Vaccine Development with Machine Learning
Released: 10-Aug-2023 10:35 AM EDT
Guiding Vaccine Development with Machine Learning
Pacific Northwest National Laboratory

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

   
Newswise: New Machine-Learning Method May Aid Personalized Cancer Therapy
Released: 9-Aug-2023 11:00 AM EDT
New Machine-Learning Method May Aid Personalized Cancer Therapy
Johns Hopkins Medicine

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.

   
Newswise: Community Conversations: A Jump-Start to a Healthy School Year
Released: 8-Aug-2023 11:35 AM EDT
Community Conversations: A Jump-Start to a Healthy School Year
Cedars-Sinai

Cedars-Sinai and BlackDoctor.org will host a virtual community conversation to help kick-off the back-to-school season.

Newswise: First steps towards a new vaccine for childhood ear infections
Released: 8-Aug-2023 8:25 AM EDT
First steps towards a new vaccine for childhood ear infections
University of Adelaide

University of Adelaide researchers have started work on developing a new vaccine that could help ward off painful ear infections in children. The potential vaccine is in the initial stages of development in the lab and will target one of the main types of bacteria that cause middle ear infections, a common illness among infants and young children.

Released: 4-Aug-2023 10:40 AM EDT
An adjuvanted intranasal vaccine for COVID-19 protects both young and old mice
Michigan Medicine - University of Michigan

A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops COVID infection in both young and old mice.

Released: 2-Aug-2023 1:25 PM EDT
One year post-COVID-19 mass vaccination, immunization coverage is higher among those eligible for priority vaccination
University of Tsukuba

At the beginning of the mass vaccination against COVID-19 infection, the government had to determine eligibility for priority vaccination.

Newswise: Extroverts More Likely to Resist Vaccines, Study Shows
Released: 2-Aug-2023 5:00 AM EDT
Extroverts More Likely to Resist Vaccines, Study Shows
University of Texas at El Paso

Which types of personalities were more hesitant about COVID-19 vaccination during the pandemic’s peak? Extroverts — according to a new study on more than 40,000 Canadians.

   
Released: 1-Aug-2023 5:30 PM EDT
Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable
University of Gothenburg

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

Released: 1-Aug-2023 9:05 AM EDT
COVID-19 Vaccines: What Parents Need to Know Now
Children's Hospital Los Angeles

The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn’t gone—and neither is the risk of getting the disease. For parents, navigating when to get their child vaccinated and knowing how to best protect their child from COVID-19 can be complicated. We spoke to Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control at Children’s Hospital Los Angeles, to get an update on the latest COVID-19 vaccine information and precautions.

Released: 31-Jul-2023 12:00 PM EDT
Duke Clinical Research Institute launches long COVID trials through NIH RECOVER Long COVID Initiative
Duke Clinical Research Institute

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies.

Newswise: Asymptomatic infections may underlie recent rise in whooping cough
Released: 26-Jul-2023 1:35 PM EDT
Asymptomatic infections may underlie recent rise in whooping cough
La Jolla Institute for Immunology

In a new study, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions of the whooping cough vaccine. The unexpected findings may help explain the recent rise in whooping cough cases and point to potential targets for the next generation of vaccines.

   


close
2.80181